Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab ‐paclitaxel for high‐risk early‐stage breast cancer

The Breast Journal, EarlyView.
Source: The Breast Journal - Category: Cancer & Oncology Source Type: research